KEYSER D JEFFREY 4
4 · Lantern Pharma Inc. · Filed Jul 26, 2024
Insider Transaction Report
Form 4
KEYSER D JEFFREY
Director
Transactions
- Exercise of In-Money
Common stock
2024-07-24$3.13/sh+3,832$11,994→ 0 total - Exercise of In-Money
Series A Warrants
2024-07-24−3,832→ 0 totalExercise: $3.13From: 2019-07-25Exp: 2024-07-25→ Common Stock (3,832 underlying)
Footnotes (1)
- [F1]On July 24, 2024, the Reporting Person exercised a Series A Warrant to purchase 3,832 shares of common stock at an exercise price of $3.13 per share.